Solta Medical, a division of Bausch Health US, LLC
$585.9K 1,270 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Optos, Inc.
Optos, Inc. reported $585,272.91 across General Payments, Research, and Ownership to 2,911 physicians and teaching hospitals across 2,911 transactions.
- $585.3K Above-median payer
- All-tracks total
- 2,911 Top quartile volume
- Transactions
- 2,911 Top quartile reach
- Recipients
- +$242.2K
- General Payments vs PY2023
Optos, Inc. reported $585,272.91 across all CMS Open Payments tracks (General + Research + Ownership) to 2,911 physicians and teaching hospitals in Program Year 2024 - ranking #728 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $585,272.91, averaging $201.06 per recipient.
How Optos, Inc.'s $585.3K all-tracks total breaks down
Optos, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
39/100
Total payments
F
15/100
Transaction volume
F
31/100
Physician reach
F
32/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer optos-inc Optos, Inc.
$585.3K · #728/1,925 · 0.0% industry · PY2024
- TOT $585.3K
- RANK #728
- SHARE 0.0%
- TXN 2,911
- RCP 2,911
- CAT 6
- GEN $585.3K
- ΔGEN +$242.2K
- TOP1 21.0%
- PY 2024
Volume peers
Nearest volume peer: Solta Medical, a division of Bausch Health US, LLC ($585.9K)
Optos, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Optos, Inc.'s CMS-reported General Payments increased by $242.2K (+70.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: OPTOS, INC.PY2023: OPTOS, INC.PY2024: Optos, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $343,051.53
- PY2024
- $585,272.91
What the Data Shows for Optos, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Optos, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Debt Forgiveness" at $395.2K, accounting for 67.5% of this company's General Payments and 13 transactions.
General Payment Breakdown by Type
Across 6 types of general payments, Optos, Inc.'s largest category was "Debt Forgiveness" at $395.2K - 67.5% of General Payments.
Optos, Inc. reports 6 general-payment categories - the top three are Debt Forgiveness (67.5%), Entertainment (28.4%), and Honoraria (3.1%). The remaining 3 categories make up 1.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Optos, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Debt Forgiveness | $395.2K | 13 | 67.5% |
| Entertainment | $166.3K | 2,876 | 28.4% |
| Honoraria | $18.0K | 14 | 3.1% |
| Travel and Lodging | $3.8K | 6 | 0.7% |
| Consulting Fee | $2.0K | 1 | 0.3% |
| Food and Beverage | $18.96 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $368,667.34 (63.0%) of $585,272.91 in this company's General Payments records across 2,099 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Optos, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Alan Winkelstein
$122,817.72 across 1 reported transactions
- 2
Mark Benjamin
$110,160.00 across 1 reported transactions
- 3
David Wichnoski
$107,239.28 across 1 reported transactions
- 4
Gregory O'connor
$15,630.01 across 1 reported transactions
- 5
Mohammad Reza Rafieetary
$12,820.33 across 16 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Optos, Inc.'s spend rank (#728 of 1,925, top 38% by spend) and concentration rank (#966 of 1,838, bottom 47% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Instylla, Inc. : $144.2K total payments, HHI 1169
- Reprise Biomedical, Inc. : $117.0K total payments, HHI 1168
- DentalEZ Alabama, Inc. : $5.9K total payments, HHI 1168
- Hollister Incorporated : $45.3K total payments, HHI 1167
- Kamada Ltd. : $83.4K total payments, HHI 1166
- Pulpdent Corporation : $80.0K total payments, HHI 1162
- Optos, Inc. (this company) : $585.3K total payments, HHI 1153
- HemoSonics LLC : $100.7K total payments, HHI 1152
- Intercept Pharmaceuticals, Inc. : $2.8M total payments, HHI 1149
- Asensus Surgical, Inc. : $207.1K total payments, HHI 1147
- Alcresta Therapeutics, Inc. : $170.2K total payments, HHI 1141
- Pathway Medical Partners, LLC : $66.0K total payments, HHI 1140
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Optos, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Optos, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Optos, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Veru Inc.
$582.2K 13 recipients
Compare payment profiles
Aroa Biosurgery Incorporated
$591.0K 3,872 recipients
Compare payment profiles
Meridian Bioscience Inc.
$577.0K 246 recipients
Compare payment profiles
Zest Holdings, LLC
$571.1K 1,385 recipients
Compare payment profiles
Hyperfine Operations, Inc.
$568.6K 56 recipients
Compare payment profiles
Put this to use
Optos, Inc. ranks #728 of 1,925 by all-tracks total payments, led by "Debt Forgiveness".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Debt Forgiveness" spend across every manufacturer, not just Optos, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.